Adaptimmune therapeutics' chief medical officer sells $3,243 in stock
Officer of Adaptimmune Therapeutics PLC (NASDAQ:ADAP), executed a sale of 5,584 American Depositary Shares (ADS) on January ...
Adaptimmune therapeutics COO sells shares worth $3,243
In a recent transaction, William C. Bertrand Jr., the Chief Operating Officer of Adaptimmune Therapeutics PLC (NASDAQ:ADAP), ...